LL-37 After the 2026 Crackdown: A Molecule With a Narrow Safety Margin, and a Market Learning to Respect It

Every antimicrobial peptide has a job it evolved to do, and LL-37’s job is close combat. It punches holes in bacterial membranes, calls in immune cells, and helps stitch tissue back together once the fight is over. That is legitimate,…